designer491/iStock via Getty Images A new Congressional Budget Office report that found coverage of weight loss drugs would cost Medicare $35B from 2026 to 2034 could mean that those medicines are excluded. The Treat and Reduce Obesity Act (H.R.
4818, S. 2407), currently winding its way through Congress, would permit CMS to.
